Bladder Neoplasm: Clinical Trials

26 trials for Bladder Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 7 completed, 5 recruiting, 3 terminated. 11 Not applicable, 3 Phase 1, 3 Phase 2, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 4, Unknown 4, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1
Phase 13Completed 1, Recruiting 1, Terminated 1
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Phase 33Terminated 2, Recruiting 1
Early Phase 11Unknown 1

Follow Bladder Neoplasm: new trials by email Literature Review of Bladder Neoplasm trials Research Report on Bladder Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
[89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor
Phase 1RecruitingRobert Flavell, MD, PhD402026-06-152026-10-01
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging - Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Not applicableRecruitingThomas Jefferson University702025-12-232026-02-17
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
multiparametric magnetic resonance imaging (mpMRI) of the bladder, Transurethral resection of bladder tumour (TURBt), Circulating tumour DNA levels assessment - Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy
Phase 3RecruitingUniversity of Rome Tor Vergata922025-08-152025-07-24
Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial
The study is to evaluate the use of the Virtuoso Endoscopy System to perform safe and effective bladder lesion excisions. - Bladder Neoplasm
Not applicableEnrolling by invitationVirtuoso Surgical, Inc.302025-04-172026-06-29
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
Sacituzumab Govitecan + Zimberelimab - Bladder Cancer, Bladder Urothelial Carcinoma
Phase 2Not yet recruitingFondazione IRCCS Istituto Nazionale dei Tumori, Milano632024-12-022024-07-30
Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)
Daily Activity Goal and Feedback - Bladder Cancer, Bladder Neoplasm
Not applicableUnknownUniversitätsmedizin Mannheim1642023-03-142024-05-16
Comparison of Interfascial Injection Versus Subpectineal Injection on Ultrasound-guided Obturator Nerve Block
Interfascial Injection, Subpectineal Injection - Bladder Neoplasm
Not applicableCompletedDiskapi Teaching and Research Hospital602022-09-162023-04-25
Personalized Urine Biomarker for Patients With Bladder Cancer
TURBT - Bladder Neoplasm
UnknownZiv Hospital202022-08-012022-07-20
Smurf2 Gene Expression in Urinary Tract Tumors
immunohistochemistry of tumors samples - Bladder Neoplasm
UnknownZiv Hospital502021-12-012021-12-16
Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block
pudendal nerve block - Bladder Neoplasm, Prostatic Neoplasms
Early Phase 1UnknownArmed Forces Hospital, Pakistan2502021-08-102021-08-26
En Bloc TURBT With Collins Loop vs Conventional TURBT
En bloc TURBT Collins Loop, Conventional TURBT - Bladder Cancer, Bladder Neoplasm
Not applicableUnknownHospital Universitario de Fuenlabrada802021-04-012021-08-30
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
Bipolar transurethral modified en bloc resection of bladder tumour - Bladder Cancer, Bladder Neoplasm
Not applicableCompletedChinese University of Hong Kong302020-09-072026-10-27
En-Bloc Resection of Bladder Tumors
En Bloc Resection, Conventional Transurethral Resection Bladder Tumor (Mono/Bipolar) - Bladder Neoplasm
Phase 2UnknownBetul Kartal602020-04-012022-04-12
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
IK-175, IK-175 and nivolumab - Urothelial Carcinoma, Urothelial Carcinoma Bladder
Phase 1CompletedIkena Oncology782019-12-182024-03-15
Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT
Bipolar En bloc TURBT, Monopolar En bloc TURBT - Bladder Cancer, Bladder Neoplasm
Not applicableUnknownBenha University2002019-11-012022-07-19
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm
Phase 3TerminatedMedical Enterprises Ltd.52019-04-042020-04-15
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Radiation therapy - Oncology, Breast Cancer
RecruitingUMC Utrecht80002019-02-012026-03-05
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
Multi-parametric MRI - MRI Contrast Media Adverse Reaction, Bladder Cancer
Not applicableActive not recruitingMansoura University1502019-01-012024-10-30
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
MicroRNAs-155, Human telomerase reverse transcriptase - Bladder Cancer, Bladder Disease
Not applicableCompletedMansoura University1152018-08-012019-11-04
Pre-Operative Single Shot Rectus Sheath Block
Rectus sheath block, Bilateral rectus sheath catheter, Patient controlled opioid analgesia (PCA) - Bladder Neoplasm, Prostate Neoplasm
Not applicableCompletedUniversity of Alberta492018-02-162022-07-28

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Urinary Bladder Neoplasms (26)  ·  Carcinoma, Transitional Cell (5)  ·  Urinary Bladder Diseases (5)  ·  Neoplasms (4)  ·  Non-Muscle Invasive Bladder Neoplasms (3)  ·  Prostatic Neoplasms (3)  ·  Urologic Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Pancreatic Neoplasms (2)  ·  Recurrence (2)  ·  Urogenital Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)

Broader conditions

Female Urogenital Diseases (26)  ·  Female Urogenital Diseases and Pregnancy Complications (26)  ·  Male Urogenital Diseases (26)  ·  Urogenital Diseases (26)  ·  Neoplasms by Site (25)  ·  Urologic Diseases (25)  ·  Urogenital Neoplasms (24)  ·  Urologic Neoplasms (23)  ·  Neoplasms (22)  ·  Urinary Bladder Diseases (21)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms, Glandular and Epithelial (8)  ·  Carcinoma (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)

Interventions

Mitomycin (2)  ·  10-propargyl-10-deazaaminopterin (1)  ·  Folic Acid (1)  ·  MLN8054 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Multiparametric Magnetic Resonance Imaging (1)  ·  Nivolumab (1)  ·  Optical Imaging (1)  ·  Radiotherapy (1)  ·  Transurethral Resection of Bladder (1)  ·  Vitamin B 12 (1)  ·  sacituzumab govitecan (1)  ·  zimberelimab (1)

Sponsors

Mansoura University (3)  ·  Ziv Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Acrotech Biopharma Inc. (1)  ·  Armed Forces Hospital, Pakistan (1)  ·  Benha University (1)  ·  Betul Kartal (1)  ·  Bioniche Life Sciences Inc. (1)  ·  Chinese University of Hong Kong (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)  ·  Hospital Universitario de Fuenlabrada (1)  ·  IRCCS San Raffaele (1)  ·  Ikena Oncology (1)  ·  Medical Enterprises Ltd. (1)

Countries

United States (8)  ·  Egypt (4)  ·  Italy (4)  ·  Canada (3)  ·  Germany (3)  ·  Netherlands (3)  ·  Belgium (2)  ·  Hong Kong (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Croatia (1)  ·  Denmark (1)

Top investigators

Ahmed Mosbah, MD (2)  ·  Abdelwahab Hashem, Msc (1)  ·  Ahmed Elshal, MD (1)  ·  Ahmed Mosbah, MD, Phd (1)  ·  Bedir Ali-Eldeen, MD, Phd (1)  ·  Francesco Montorsi, MD (1)  ·  Garry Weems, Pharm.D. (1)  ·  Giuseppe Procopio, MD (1)  ·  Helena M Verkooijen, Prof, Dr (1)  ·  Jeremy Teoh (1)  ·  Jeremy YC Teoh, MBBS (1)  ·  Karim Malek, MD (1)  ·  Karl-Friedrich Kowalewski, PD Dr. med (1)  ·  Michael A O'Donnell, MD (1)

Results publications

PMID 29415874, PMID 33014774, PMID 34981300, PMID 41276423, PMID 41506574